Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
Go back to Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies| (NASDAQ: PROG) | Delayed: 0.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.88 | 52 Week High | $ | |||
| Open | $0.88 | 52 Week Low | $ | |||
| Day High | $0.88 | P/E | N/A | |||
| Day Low | $0.88 | EPS | $ | |||
| Volume | 1,821 | |||||
